About Lepure Biotech
Lepure Biotech is a company based in Shanghai (China) founded in 2011. Lepure Biotech has raised $15.22 million across 3 funding rounds from investors including General Atlantic, Huimei Healthcare and Novo Holdings. Lepure Biotech offers products and services including Single-Use Systems and Filtration Systems.
- Headquarter Shanghai, China
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Shanghai Lepure Biotech Co., Ltd
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$15.22 M (USD)
in 3 rounds
-
Latest Funding Round
Not available
-
Investors
General Atlantic
& 16 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Lepure Biotech
Lepure Biotech offers a comprehensive portfolio of products and services, including Single-Use Systems and Filtration Systems.
Single-use systems are utilized for fluid management and storage in biopharmaceutical production processes.
Filtration and purification solutions are employed for virus removal and sterilization in manufacturing applications.
Funding Insights of Lepure Biotech
Lepure Biotech has successfully raised a total of $15.22M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Lepure Biotech
Lepure Biotech has secured backing from 17 investors, including venture fund and institutional investors. Prominent investors backing the company include General Atlantic, Huimei Healthcare and Novo Holdings.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and venture capital fund focused on the healthcare sector
|
Locked | Locked | Locked | |
|
Private equity fund focused on global markets
|
Locked | Locked | Locked | |
|
Healthcare startups are funded by HLC venture capital firm.
|
Locked | Locked | Locked |
Investor details for Lepure Biotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lepure Biotech
Investment portfolio details for Lepure Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Lepure Biotech
Detailed financials for Lepure Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lepure Biotech Comparisons
Peer comparison for Lepure Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Lepure Biotech
Detailed competitors of Lepure Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lepure Biotech
Complete news archive for Lepure Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lepure Biotech
Lepure Biotech was founded in 2011 and raised its 1st funding round 10 years after it was founded.
Lepure Biotech is headquartered in Shanghai, China.
Wang Fengfrank is the current CEO of Lepure Biotech.
Lepure Biotech is a funded company, having raised a total of $15.22M across 3 funding rounds to date.
Lepure Biotech was established in 2011 in Shanghai, China. Operations focus on the biotech sector, where traditional packaging, dispensing, and storage solutions are supplied. Services include standard containers and systems for product handling and preservation. The company serves clients primarily in the Asian market, with leadership provided by CEO Wang Fengfrank. Domain lepure-bio.com is maintained for online presence.
Lepure Biotech offers Single-Use Systems and Filtration Systems.
Lepure Biotech has 17 investors. Key investors include General Atlantic, Huimei Healthcare, Novo Holdings, Honghui Fund, and Guangdong Zhongke Kechuang Venture Capital Management.